Institutional Biosafety Committee (IBC) Services Info Sheet
Advarra’s IBC services offer rapid, flexible solutions for IBC review, especially critical for gene therapy and other high-stakes research.
Reviews
Institutional Review Board (IRB) Services Info Sheet
Advarra’s Institutional Review Board (IRB) offers expert guidance, supporting more than 3,500 institutions, academic medical centers, and site networks.
Endpoint Adjudication Committee (EAC) Services Info Sheet
Secure independent evaluation and adjudication of complex clinical trial endpoints.
Canadian Institutional Review Board / Research Ethics Board Services
Leverage Advarra’s expertise in Canada as the only officially recognized IRB/REB, offering extensive site reach and top-notch research ethics services.
Single Institutional Review Board (sIRB) Services Info Sheet
As the research community’s preferred sIRB partner, we help you meet regulatory requirements with efficiency and transparency.
Gene Therapy Ready Site Network
Advarra’s GTR Site Network includes 1,500+ vetted sites worldwide, fully prepared to support clinical trials in genetic engineering and advanced therapies.
Diversity, Equity, and Inclusion in Clinical Research
Achieving diversity, equity, and inclusion (DEI) in clinical trials is crucial for producing comprehensive and effective medical research benefitting all
Decentralized Clinical Trials Involving Biologics: Unique Challenges
Join this webinar to learn about FDA insights on DCTs and biologics. Dr. Eisenman discusses biosafety, risks, and key considerations for safe trials.
Preparing Your Action Plan for the FDA sIRB Mandate
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Budgeting for IRB Review: A Guide for HRPP Leadership
At institutional research programs around the U.S., there exists a pervasive myth: internal institutional review board (IRB) reviews are free.
Understanding the Impact of the New EU Artificial Intelligence Act on Clinical Research
Artificial intelligence (AI) has taken the world by storm – and regulators are paying attention. The European Parliament recently adopted
Conducting Research With CAR T Cells
Conducting Research With CAR T Cells Regulatory and Practical Considerations Having proven successful in trials for blood cancers considered resistant